6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically Network Contracting Office 4 (36C244), has awarded a contract for Specialty Pharmaceutical Lenalidomide to EXELAN PHARMACEUTICALS INC. The award, valued at $1,007,002.66, was made on February 6, 2026, for a base period from February 13, 2026, to February 12, 2027.
Scope of Work
This contract covers the supply of Lenalidomide capsules in various strengths for the VA. The awarded quantities include:
- Lenalidomide 10MG CAP, Oral: 1,253.00 EA
- Lenalidomide 15MG CAP, Oral: 143.00 EA
- Lenalidomide 25MG CAP, Oral: 756.00 EA
Contract Details
- Contract Type: Award Notice (likely Firm Fixed-Price based on the nature of the procurement)
- Awardee: EXELAN PHARMACEUTICALS INC
- Award Value: $1,007,002.66
- Award Date: February 6, 2026
- Period of Performance: Base period from February 13, 2026, to February 12, 2027
- Product/Service Code (PSC): 6505 - Drugs and Biologicals
- NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Evaluation
The original solicitation for this requirement, titled "Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA," indicated that the award was based on a Lowest Price Technically Acceptable (LPTA) evaluation method.
Set-Aside
No specific set-aside designation was identified for this award.